Drug profile · INN
metoprolol fumarate
LOPRESSOR
metoprolol fumarate (LOPRESSOR) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — metoprolol fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
metoprolol fumarate (LOPRESSOR) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is metoprolol fumarate?
metoprolol fumarate (LOPRESSOR) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for metoprolol fumarate?
LOPRESSOR is a marketed brand name for metoprolol fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metoprolol fumarate?
metoprolol fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.